1 results match your criteria: "Groupe Universitaire Est[Affiliation]"
Paternal exposure to methotrexate and pregnancy outcomes.
J Rheumatol
April 2011
Centre de Référence sur les Agents Tératogènes (CRAT), Hôpital Armand Trousseau, Groupe Universitaire Est, Paris, France.
Objective: To assess the risk of major malformation in the case of paternal exposure to methotrexate (MTX) at the time of conception.
Methods: Using prospective data of our Teratology Information Service, we analyzed outcomes of paternal MTX exposure at the time of conception or up to 3 months before conception.
Results: We report on the outcomes of 42 pregnancies involving 40 men treated with MTX at the time of conception.